Skip to main content
logo
Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
5.50
-0.09 (-1.61%)
At close: Jan 26, 2026, 4:00 PM EST
5.50
0.00 (0.00%)
After-hours: Jan 26, 2026, 7:00 PM EST

Nuvation Bio Revenue

Nuvation Bio had revenue of $13.12M in the quarter ending September 30, 2025, with 1,704.68% growth. This brings the company's revenue in the last twelve months to $26.75M, up 1,137.19% year-over-year. In the year 2024, Nuvation Bio had annual revenue of $7.87M.

Revenue (ttm)
$26.75M
Revenue Growth
+1,137.19%
P/S Ratio
71.02
Revenue / Employee
$91,918
Employees
291
Market Cap
1.89B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20247.87M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Zai Lab441.63M
Ardelyx398.23M
Immunocore Holdings379.59M
Aurinia Pharmaceuticals265.81M
Vericel258.72M
Monte Rosa Therapeutics181.54M
Nurix Therapeutics83.69M
Revenue Rankings

NUVB News

More News